How do public 'report cards' affect physicians' treatment decisions?

May 10, 2018

BOSTON - Public "report cards" on outcomes for patients who have undergone percutaneous coronary intervention (PCI or coronary angiography) were originally developed to increase transparency and improve care, but studies have shown that these reports may inadvertently discourage physicians from offering this lifesaving treatment to patients at high risk for poor outcomes.

Researchers from the Smith Center for Outcomes Research in Cardiology at Beth Israel Deaconess Medical Center (BIDMC) now provide a closer look at physicians' knowledge, attitudes and beliefs about PCI public reporting. In a study published online today in JAMA Cardiology, the researchers describe the results of a comprehensive survey of interventional cardiologists in two states that mandate public reporting. Their overall results show that risk-averse attitudes and practice patterns remain widespread when clinical results are publicly reported.

"Our primary results showed that among the interventional cardiologists who responded, almost two-thirds reported avoiding performing an indicated coronary intervention on at least two occasions due to a concern that an adverse event might negatively affect their publicly reported outcomes," said senior author Robert W. Yeh, MD, MBA, Director of the Smith Center and an interventional cardiologist at BIDMC. "A similar number reported that they had been pressured by colleagues to avoid performing PCIs - even if it was the preferred procedure for the patient's condition - if there was a risk of a bad outcome."

The online survey was sent to 456 interventional cardiologists in Massachusetts and New York (where public reporting is mandated). The survey was developed and distributed by the Smith Center in collaboration with the Society for Cardiovascular Angiography and Interventions and the American College of Cardiology's Interventional Council.

The results showed that: "Despite reforms intended to limit reporting of outcomes for the highest-risk patients undergoing PCI, current programs continue to engender risk-averse clinical practice," said the study's first author Daniel Blumenthal, MD, MBA, an investigator in the Smith Center at BIDMC, a cardiologist at the Massachusetts General Hospital and an Instructor in Medicine at Harvard Medical School. "This is the first time we asked interventional cardiologists in multiple states in-depth questions about how these public reports influence their clinical decisions. Their answers revealed that unintended consequences of public reporting continue to undermine the policy."

"I think that when developing policies intended to improve quality of care and transparency, policy makers have to talk to the physicians to find out how these policies might change their behavior," added Yeh, who is also an Associate Professor of Medicine at Harvard Medical School. "We need more engagement and input from the people who are actually caring for the patients. While I believe there is an important place for public reporting, we always need to take into account the human factor, which may arise in unexpected ways."
-end-
In addition to Yeh and Blumenthal, coauthors include Linda R. Valsdottir, MS, Yuansong Zhao, MA, Duane Pinto, MD and Changyu Shen, PhD, of the Smith Center, BIDMC; Jason H. Wasfy, MD, MPhil, and Ken Rosenfield, MD, of Massachusetts General Hospital; Ajay J. Kirtane, MD, SM, of Columbia University Medical Center; Fred S. Resnic, MD, MSc, of Lahey Clinic; Joynt Maddox, MD, MPH of Washington University School of Medicine; and Roxana Mehran, MD, of the Icahn School of Medicine at Mount Sinai.

The study was a collaborative endeavor of the Society for Cardiovascular Angiography and Interventions, the American College of Cardiology's Interventional Council, and the Smith Center for Outcomes Research in Cardiology, BIDMC, and was funded through an investigator-initiated research grant from Abiomed, Inc.

Beth Israel Deaconess Medical Center

Related Mortality Risk Articles from Brightsurf:

Certain pre-existing conditions may double, triple mortality risk for COVID-19
A large, international study of COVID-19 patients confirmed that cardiovascular disease, hypertension, diabetes, congestive heart failure, chronic kidney disease, stroke and cancer can increase a patient's risk of dying from the virus.

Three common medications lower risk and mortality for lung cancer
Combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology (JTO).

Factors that raise the risk of mortality among children with several acute malnutrition
#AJCN review identifies independent predictors of inpatient mortality among children with severe acute malnutrition: HIV infection, diarrhea, pneumonia, shock, lack of appetite, and low weight-to-height ratio.

Risk factors for mortality in diabetic patients discharged from hospital identified
When patients are discharged from Hospital those with diabetes are at an increased risk of readmission and mortality, there are guidelines for discharging patients with diabetes to reduce these risks, however researchers from the Institute of Digital Healthcare at WMG, University of Warwick and Warwick Medical School have identified known risk factors for mortality in adult patients discharged from hospital with diabetes.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Antiepileptic drugs are associated with a higher risk of mortality in persons with Alzheimer's
The use of antiepileptic drugs is associated with a higher risk of death among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland.

IVF-conceived children have somewhat higher mortality risk in their first weeks of life
Children conceived with assisted reproductive techniques including IVF have a somewhat higher mortality risk during their first weeks of life than children conceived naturally, according to a study by researchers at Karolinska Institutet in Sweden published in the journal Fertility and Sterility.

Statins may lower mortality in high-risk prostate cancer patients
Statin use alone or with metformin is associated with lower prostate cancer mortality from all causes, among high-risk patients.

Hospital readmission policy did not increase patients' mortality risk
The Obamacare program intended to reduce the risk of patients being readmitted after hospitalizations for heart attacks, heart failure, and pneumonia has not caused an increase in mortality risk for patients in emergency departments or observational units, according to a new report.

Air pollution may increase mortality risk after heart transplant
Heart transplant recipients who live in areas where particulate matter (PM2.5) air pollution levels reached above national limits for clean air had a 26% higher risk of mortality due to infection, according to a study published today in the Journal of the American College of Cardiology.

Read More: Mortality Risk News and Mortality Risk Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.